Share on StockTwits
Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Viridian to Moderate Institutional Investor Panel at NCIA's CannaVest Event in Boston


New York, NY - February 8, 2019 ( Newswire) Viridian Capital Advisors is pleased to announce that Scott Greiper, its President and Founder, will moderate the institutional investment panel at NCIA's (National Cannabis Industry Association) CannaVest Institutional Capital Forum, part of its larger Seed to Sale Show taking place at The Hynes Convention Center in Boston, Massachusetts on Tuesday, February 12 and Wednesday, Februrary 13.

Scott's session, entitled "Risk Adjusted Investment Returns in Legal Cannabis: A Look at Private Equity, Venture Capital, and Real Estate Investing", is scheduled to take place from 11:15am ET to 12:15pm ET on Tuesday, February 12. The panel will focus on identifying investment opportunities, vetting management teams, achieving portfolio diversification, differences between "touching the plant" and ancillary investments, and common pushbacks when raising capital.

Scott will be joined by panelists Matt Hawkins of Cresco Capital, John Brecker of Altitude Investment Management, Mitch Baruchowitz of Merida Capital Partners, Steve Kaplan of Ladenburg Thalmann, and Brett Finkelstein of Phyto Partners.

To learn more about NCIA's event, including Scott Greiper's session, click here or on the image below:

NOTE: No securities will be offered during this event.

About Viridian Capital Advisors, LLC

Viridian Capital Advisors ( is a financial and strategic advisory firm dedicated to the cannabis market. We are a data- and market intelligence-driven firm that provides investment banking, M&A, corporate development, and investor relations services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, LLC (Member FINRA/SIPC), provides capital and M&A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team's decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.

Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.


Harrison Phillips
Vice President
Viridian Capital Advisors, LLC

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories